{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for icosapent root_names_stdName in Standardized Name (approximate match)
Status:
Investigational
Source:
INN:calotatug ginistinag [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tilatamig samrotecan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03262935: Phase 3 Interventional Completed Metastatic Breast Cancer
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
USAN:IMMUNE GLOBULIN INTRAVENOUS PENTETATE [USAN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:trastuzumab pamirtecan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:precemtabart tocentecan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:lonigutamab ugodotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:garetatug rezetecan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tivinectide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:efitazanamivir alfa [INN]
Source URL:
Class:
PROTEIN